NCT06556186View on ClinicalTrials.gov

Surgical and Pharmacological Efficacy of Knosp Grade 0-2 Prolactinoma

NANot yet recruitingINTERVENTIONAL
Enrollment

600

Participants

Timeline

Start Date

October 1, 2024

Primary Completion Date

March 31, 2027

Study Completion Date

March 31, 2027

Conditions
Pituitary Tumor
Interventions
PROCEDURE

Transnasal transsphenoidal pituitary lesion resection under neuroendoscopy

Transnasal transsphenoidal pituitary lesion resection under neuroendoscopy

DRUG

Bromocriptin 2.5mg, 2-3 times a day

Bromocriptin 2.5mg, 2-3 times a day

All Listed Sponsors
collaborator

Peking Union Medical College Hospital

OTHER

collaborator

West China Hospital

OTHER

collaborator

First Affiliated Hospital of Wenzhou Medical University

OTHER

collaborator

Ningbo Medical Center Lihuili Hospital

OTHER_GOV

lead

Second Affiliated Hospital, School of Medicine, Zhejiang University

OTHER